Citadel Advisors’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$296K Sell
145,999
-5,462
-4% -$11.1K ﹤0.01% 4634
2025
Q1
$283K Buy
151,461
+143,598
+1,826% +$269K ﹤0.01% 4552
2024
Q4
$21.2K Sell
7,863
-13,943
-64% -$37.6K ﹤0.01% 5638
2024
Q3
$82.4K Sell
21,806
-13,002
-37% -$49.1K ﹤0.01% 4992
2024
Q2
$139K Sell
34,808
-25,924
-43% -$103K ﹤0.01% 4813
2024
Q1
$180K Buy
+60,732
New +$180K ﹤0.01% 4839
2023
Q4
Sell
-1,097
Closed -$3.13K 5823
2023
Q3
$3.13K Buy
+1,097
New +$3.13K ﹤0.01% 5576
2023
Q2
Sell
-3,165
Closed -$7.41K 5739
2023
Q1
$7.41K Sell
3,165
-163,898
-98% -$384K ﹤0.01% 5567
2022
Q4
$341K Buy
+167,063
New +$341K ﹤0.01% 4219
2022
Q3
Hold
0
5804
2022
Q2
Hold
0
5938
2022
Q1
Sell
-25,613
Closed -$127K 6265
2021
Q4
$127K Sell
25,613
-10,427
-29% -$51.7K ﹤0.01% 5769
2021
Q3
$242K Buy
36,040
+14,273
+66% +$95.8K ﹤0.01% 5216
2021
Q2
$172K Sell
21,767
-15,027
-41% -$119K ﹤0.01% 5676
2021
Q1
$280K Buy
+36,794
New +$280K ﹤0.01% 5111
2020
Q4
Sell
-23,970
Closed -$117K 5025
2020
Q3
$117K Buy
+23,970
New +$117K ﹤0.01% 4218
2020
Q2
Sell
-42,946
Closed -$297K 4581
2020
Q1
$297K Sell
42,946
-39,222
-48% -$271K ﹤0.01% 3800
2019
Q4
$700K Sell
82,168
-38,169
-32% -$325K ﹤0.01% 3300
2019
Q3
$595K Sell
120,337
-46,090
-28% -$228K ﹤0.01% 3349
2019
Q2
$924K Buy
166,427
+42,414
+34% +$235K ﹤0.01% 3043
2019
Q1
$626K Sell
124,013
-325,525
-72% -$1.64M ﹤0.01% 3206
2018
Q4
$4.25M Buy
449,538
+164,701
+58% +$1.56M ﹤0.01% 1606
2018
Q3
$2.28M Buy
+284,837
New +$2.28M ﹤0.01% 2116
2018
Q2
Sell
-15,743
Closed -$163K 4122
2018
Q1
$163K Sell
15,743
-61,849
-80% -$640K ﹤0.01% 3535
2017
Q4
$993K Hold
77,592
﹤0.01% 2392
2017
Q3
$877K Sell
77,592
-63,101
-45% -$713K ﹤0.01% 2364
2017
Q2
$1.24M Sell
140,693
-35,112
-20% -$309K ﹤0.01% 2017
2017
Q1
$1.82M Sell
175,805
-197,668
-53% -$2.05M ﹤0.01% 1731
2016
Q4
$4.85M Buy
373,473
+298,615
+399% +$3.88M ﹤0.01% 1074
2016
Q3
$1.23M Buy
+74,858
New +$1.23M ﹤0.01% 1819